Capecitabine for locally advanced and metastatic colorectal cancer: A review

doi:10.4251/wjgo.v2.i8.311

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 2, Issue 8

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4656)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-4) series.

Item

Count

PDF

405

HTML

3837

Figures (1-1)

156

Tables (1-4)

258

Sum=4656

Aug 15, 2010 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (17)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Gastrointest Oncol. Aug 15, 2010; 2(8): 311-321
Published online Aug 15, 2010. doi: 10.4251/wjgo.v2.i8.311

Open in New Tab Full Size Figure Download Figure

Figure 1 Metabolic conversion of capecitabine to fluorouracil in three consecutive steps. 5’-DFCR: 5’-deoxy-S-fluorocytidine; Cyt D: Cytidine deaminase; 5-FU: 5-Fluorouracil; TP: Thymidine phosphorylase.

Citation: Koukourakis GV, Zacharias G, Tsalafoutas J, Theodoridis D, Kouloulias V. Capecitabine for locally advanced and metastatic colorectal cancer: A review. World J Gastrointest Oncol 2010; 2(8): 311-321
URL: https://www.wjgnet.com/1948-5204/full/v2/i8/311.htm
DOI: https://dx.doi.org/10.4251/wjgo.v2.i8.311